Nick is joined by Dr.⁠Muhunthan Thillai⁠, the co-founder and CEO of ⁠Qureight⁠ and they discuss the innovative way they are using AI to allow for effective drug development in complex diseases. This is also a fantastic episode for understanding how founders from a medical background have built an AI company.

Dr.Muhunthan Thillai is the co-founder and CEO of Qureight, a medical technology company in Cambridge which aims to pioneer data curation in complex diseases. By structuring image and biomarker data from biopharma and healthcare institutions, Qureight uses their AI-assisted platform to look for new trial endpoints in complex diseases including Idiopathic Pulmonary Fibrosis, Lung Cancer and Pulmonary Hypertension.